Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

计划入组 9 人 · 首次发布于 2014 年 2 月 20 日

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

计划入组 10 人 · 首次发布于 2023 年 6 月 12 日

Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)

计划入组 450 人 · 首次发布于 2008 年 6 月 18 日

Fluorouracil(Actikerall, Carac, Efudex, Fluoroplex, Tolak)

C₄H₃FN₂O₂ · Rx

small molecule therapeutic (basal cell carcinoma)

basal insulin (Biodel)

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Medicus Pharma Partners with Gorlin Syndrome Alliance to Advance Compassionate Access for SKINJECT™ Microneedle Therapy

Medicus Pharma Seeks Orphan Drug Designation for SkinJect in Rare Gorlin Syndrome

Basal Cell Neoplasm Drug Pipeline Expands with 22+ Companies Developing Novel Therapies